Please see prior post here: http://www.emdocs.net/reversal-of-anticoagulation/
On October 16, 2015 the FDA granted accelerated approval of idarucizumab (Praxbind), a novel reversal agent of the direct thrombin inhibitor Dabigatran (Pradaxa), for utilization in life-threatening bleeding emergencies.1
Reversal of Anticoagulation in a True Emergency – An Update Read More »
I HAVE BECOME INFATUATED WITH THE PATIENT CARE EXPERIENCE. I believe the term “patient care experience” is a more inclusive term that describes our technical expertise while also including everything else, such as communication, department ambience, throughput, and the behavior of everyone a patient comes into contact with while in the department.
“As one develops a skill set, FOAM becomes a more valued tool for fine-tuning your already engrained knowledge”
Coverage of the FOAMed workshop at CORD 2014 from Adaira Landry, MD (@allarounddoc), with a primer on how to get involved in the social media and medical education movement.
#dontgetleftbehind: FOAMed and Social Media for EM Educators Read More »
